Salmon PDRN vs Plant PDRN for Cosmetic Formulations

Salmon PDRN vs plant PDRN is often reduced to one claim: salmon has the stronger evidence history, while plant PDRN offers an animal-free alternative. That distinction matters, but it is not enough for raw-material approval.

A high-assay salmon PDRN powder and a plant PDRN solution may carry the same PDRN label while differing in active content, physical form, molecular profile, carrier system and supporting evidence. Even two plant-derived products may come from different botanical sources and production processes.

For cosmetic formulators and sourcing teams, the right question is not simply “Which source is better?” It is “Which documented commercial grade fits the formula, target market and product positioning?”

Is Salmon or Plant PDRN Better for Cosmetic Formulations?

Salmon PDRN generally refers to purified DNA fragments obtained from salmonid reproductive tissue. It has the longer research history, although much of the published evidence comes from pharmaceutical, injectable, wound-care or other route-specific applications rather than conventional topical cosmetics.

Plant PDRN is a broader and less standardized commercial category. Published research has examined DNA fractions from individual sources such as Panax ginseng, peony and rose. Microbial-derived PDRN is another emerging animal-free route, but it should not be treated as identical to botanical PDRN.

Neither source is universally better. Compare the exact grade on four levels:

• Identity: source, production route and supported cosmetic ingredient declaration;
• Delivered material: powder, solution or blend, including carrier and preservative composition;
• Technical data: PDRN content, assay basis, molecular profile and test methods;
• Project fit: formulation behavior, evidence scope and animal-origin requirements.

What Do “Salmon PDRN” and “Plant PDRN” Describe?

PDRN, or polydeoxyribonucleotide, is used for mixtures of deoxyribonucleotide chains or fragments. These materials are polydisperse. A commercial batch therefore contains chains of different lengths rather than one molecule with a single fixed molecular weight.

Salmon-Derived PDRN

The established literature generally describes PDRN purified from the sperm DNA of salmon trout (Oncorhynchus mykiss) or chum salmon (Oncorhynchus keta). Commercial grades can still differ in source species, extraction and fragmentation process, assay, residual protein, molecular-weight distribution and release limits.

“Salmon PDRN” identifies the biological origin. It does not define one universal purity, molecular range or cosmetic grade.

Plant-Derived PDRN

Plant PDRN and phyto-PDRN are commercial terms used for DNA-derived ingredients obtained from specified botanical sources. Ginseng, peony and rose are among the sources examined in published studies.

The exact source matters. Results obtained with ginseng-derived PDRN do not automatically substantiate a rose- or peony-derived grade. A botanical extract containing a small DNA fraction should also not be assumed equivalent to a characterized PDRN ingredient.

“Vegan PDRN” is wider marketing language. It may include plant- and microbial-derived options, but animal-free or vegan positioning still requires appropriate supply-chain and formulation documentation.

Salmon PDRN vs Plant PDRN: Procurement Comparison

The table is a screening framework. The current specification, composition statement and batch documentation take priority over category-level assumptions.

Compare Delivered PDRN Content Before Price or Dosage

The recommended use level of a powder cannot be compared directly with the recommended use level of a solution. “Use at 1%” describes the amount of supplied raw material entering the formula. It does not necessarily describe the amount of PDRN in the finished product.

For a solution whose PDRN content is expressed in ppm:

For example, adding a solution specified at NLT 5,000 ppm PDRN at 1% would nominally contribute at least 50 ppm PDRN to the finished formula, assuming both figures use a compatible weight basis.

By comparison, adding a powder with a minimum 90% assay at 1% would nominally contribute at least 0.9% assayed material, equivalent to at least 9,000 ppm. The assay method and whether the result is calculated as-is or on a dry basis must still be checked.

These calculations do not establish an effective cosmetic dose. They show why two ingredients carrying the same PDRN label may not be dose-equivalent or price-equivalent.

Renew’s current published cosmetic grades illustrate the difference:

For teams evaluating a high-assay powder format, review Renew’s cosmetic-grade PDRN powder page for the current specification, sample and batch-document information.

For commercial evaluation, calculate the cost per gram of declared PDRN as well as the price per kilogram of supplied material. Then consider handling, preservation, stability and the dosage that performs acceptably in the intended formula.

What Does the Published Evidence Actually Support?

The evidence does not justify a simple “salmon works, plant does not” conclusion. It also does not show that every plant PDRN is equivalent to established salmon-derived materials.

Salmon PDRN: Deeper Evidence, but Route Matters

Salmon-derived PDRN has the longer pharmacological research history. A widely cited review of PDRN pharmacology and clinical use describes studies involving tissue repair, inflammatory pathways, angiogenesis and nucleotide salvage mechanisms.

However, many studies involve injections, experimental wounds, medicated dressings or other non-routine cosmetic conditions. Those results provide scientific context. They do not by themselves prove that a topical serum applied to intact skin will produce the same outcome.

A cosmetic supplier or brand should therefore separate three questions:

• Is the offered raw material comparable to the material used in the study?
• Was the evidence generated using a relevant topical route and concentration?
• Has the finished formula been tested for the intended cosmetic claim?

Plant PDRN: Promising but Source-Specific

Plant-derived evidence is growing, but the test materials are not interchangeable.

A 2023 study of PDRN isolated from Panax ginseng adventitious root reported effects in human skin cells and a 3D skin model, including findings related to A2A-receptor signaling. The results support the tested ginseng material and study conditions—not the entire plant PDRN category.

A study of low-molecular-weight peony PDRN included cell and UV-stress experiments plus a small topical evaluation. The human test used a 1% cream and included ten participants per group. The authors identified the small sample, short duration and lack of an active comparator as limitations.

Research has also examined rose-derived PDRN and microbial-derived PDRN. These studies expand the evidence base, but each applies to its own source, preparation and test conditions.

The correct procurement conclusion is not that plant PDRN lacks value. It is that the supplier must identify the source and show why the evidence is relevant to the offered grade.

Molecular Weight Does Not Prove Skin Penetration

Plant PDRN is sometimes promoted as smaller and therefore better suited to topical absorption. Salmon PDRN is sometimes promoted as more effective because of its established biological origin. Neither statement is sufficient without grade-specific data.

Molecular information may be reported in base pairs, kDa, a broad range, an average or a dominant fraction. Two grades with a similar average can still have different distributions. Test method, sample preparation, aggregation and processing conditions may also affect the result.

Smaller fragments may behave differently in a formulation, but lower molecular weight alone does not prove meaningful passage through intact skin. The peony PDRN study noted that direct skin-penetration testing was still needed.

When reviewing a grade, ask what the reported number represents, which method was used and whether the result belongs to the commercial batch being offered. For more detail on chain terminology, see PDRN vs PN for Cosmetics: Molecular Weight & Grade Selection.

How to Qualify a Salmon or Plant PDRN Grade

Source selection should end with document review and formula testing. The following checks are more useful than choosing by origin alone.

Review the Commercial Grade

• Confirm the exact biological source, production route and supported cosmetic ingredient declaration.
• Identify every component in a solution or blend, including carrier, preservative and botanical co-extracts.
• Check whether PDRN is reported as assay, DNA content, solids or another measurement, and confirm the calculation basis.
• Review molecular-weight or fragment-size data together with the method and reported metric.
• Compare microbiological, heavy-metal, moisture, protein and relevant residual-process limits.
• Match the batch COA to the agreed specification and confirm that the sample represents the intended commercial grade.

The European Commission’s CosIng database includes SODIUM DNA/RNA. However, CosIng is an informational database; a listing does not approve every commercial material or determine its correct declaration in every market.

For animal-free positioning, request the relevant animal-origin statement and any documents required by the brand, retailer or certification program. A plant source alone does not establish that the complete ingredient and finished formula meet a particular vegan standard.

Compare the Grades in the Intended Formula

1. Screen both candidates at commercially realistic dosages and calculate their nominal PDRN contribution.
2. If practical, run a second comparison at the same nominal PDRN content.
3. Record dissolution or dispersion time, color, odor, clarity, pH and viscosity.
4. Check compatibility with the preservative system, polymers, electrolytes and packaging.
5. Complete the required stability, microbiological, safety and claim testing on the finished formula.

If a dilute solution cannot reach the same nominal active level at a practical dosage, the two products may serve different formulation or positioning roles rather than act as direct substitutes.

Which Source Fits the Project?

Salmon PDRN is not automatically the better cosmetic ingredient because its research history is longer. Plant PDRN is not automatically the more suitable topical ingredient because it is animal-free or may have smaller fragments. The decision must remain grade- and formula-specific.

Final Selection Principle

Salmon PDRN vs plant PDRN is ultimately a comparison between documented commercial grades, not two source labels.

Start with identity and delivered form. Normalize PDRN content before comparing dosage or price. Then review the analytical methods, evidence scope, ingredient-positioning requirements and performance in the intended formula.

Renew supplies separate cosmetic salmon PDRN powder and plant PDRN solution grades. Share your target formula, destination market, expected dosage and required documents. Renew can provide the current specification, available batch information and sample options for grade-level evaluation.

Technical References and Scope

This article addresses cosmetic raw-material comparison and procurement. It does not establish the regulatory status, safety or efficacy of a finished product. Manufacturers remain responsible for formula testing, safety assessment, ingredient declaration, regulatory review and claim substantiation in each destination market.

• Squadrito, F. et al. “Pharmacological Activity and Clinical Use of PDRN.” Frontiers in Pharmacology. 2017;8:224.
• Lee, K.-S. et al. “Analysis of Skin Regeneration and Barrier-Improvement Efficacy of Polydeoxyribonucleotide Isolated from Panax Ginseng Adventitious Root.” Molecules. 2023;28(21):7240.
• Chae, D. et al. “First Report on Microbial-Derived Polydeoxyribonucleotide.” Current Issues in Molecular Biology. 2025;47(1):41.
• Bak, S.U. et al. “Anti-Aging Efficacy of Low-Molecular-Weight Polydeoxyribonucleotide Derived from Paeonia lactiflora.” International Journal of Molecular Sciences. 2026;27(1):220.
• Cavagnino, A. et al. “Modulating Skin Aging Molecular Targets Through Rose-Derived Polydeoxyribonucleotide.” Current Issues in Molecular Biology. 2025;47(12):971.
• European Commission. “CosIng entry: SODIUM DNA/RNA” and “Cosmetic Ingredient Database Notice.”